SCHEMBL16995488

SCHEMBL16995488

CCOc1c(F)cc(-c2csc(N)n2)cc1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.54
ALDH1A1 P00352 5/20 0.54
NPC1 O15118 5/20 0.54
SMN1; SMN2 Q16637 5/20 0.54
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
ALOX5 P09917 1/20 0.46
MAPT P10636 4/20 0.45
KDM4E B2RXH2 1/20 0.45
MPL P40238 4/20 0.44
HSD17B10 Q99714 1/20 0.44
POLB P06746 2/20 0.43
LTA4H P09960 4/20 0.41
LMNA P02545 1/20 0.41
RECQL P46063 1/20 0.41
NFKB1 P19838 1/20 0.40
MAPK1 P28482 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
EGFR P00533 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10171329 0.86 RAB9A (0.49) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL475099 0.84 RAB9A (0.50) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL474234 0.84 ALDH1A1 (0.53) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL1801918 0.83 ALDH1A1 (0.66) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL474243 0.82 MPL (0.52) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL474416 0.82 ALDH1A1 (0.48) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL474173 0.80 MPL (0.47) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL474265 0.80 FFAR4 (0.46) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL15580577 0.78 FFAR4 (0.49) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL17412665 0.77 ALDH1A1 (0.56) RAB9AALDH1A1NPC1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2708538-B1 Process for preparing fused pyrimidine-dione derivatives, useful as as TRPA1 modulators GLENMARK PHARMACEUTICALS SA (CH) 2015-08-12 EP disclosed